SureTrader
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

You can find the numbers I gove in

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
tilator Member Profile
 
Followed By 0
Posts 264
Boards Moderated 0
Alias Born 09/14/17
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/16/2018 6:32:05 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 11:13:52 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/14/2018 6:54:36 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/9/2018 8:08:58 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/24/2018 8:04:28 AM
Intellipharmaceutics Provides Operational Update GlobeNewswire Inc. - 1/24/2018 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/5/2017 8:05:20 AM
Intellipharmaceutics Announces Receipt of Nasdaq Notice GlobeNewswire Inc. - 12/5/2017 8:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/4/2017 5:21:01 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/30/2017 10:51:14 AM
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical GlobeNewswire Inc. - 11/30/2017 10:45:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/20/2017 5:20:34 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 10/18/2017 3:20:22 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/16/2017 6:03:43 AM
Intellipharmaceutics Announces Closing of US$4 Million Financing GlobeNewswire Inc. - 10/13/2017 5:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/13/2017 6:04:15 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/12/2017 4:07:48 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2017 8:07:45 AM
Intellipharmaceutics Announces US$4 Million Registered Direct Offering GlobeNewswire Inc. - 10/11/2017 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/10/2017 5:25:56 PM
Intellipharmaceutics Announces Third Quarter 2017 Results GlobeNewswire Inc. - 10/10/2017 5:20:59 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/25/2017 7:12:00 AM
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA GlobeNewswire Inc. - 9/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/20/2017 5:18:47 PM
Intellipharmaceutics Announces Receipt of Nasdaq Notice GlobeNewswire Inc. - 9/20/2017 5:10:00 PM
tilator   Friday, 11/10/17 04:59:49 PM
Re: tilator post# 31213
Post # of 32835 
You can find the numbers I gove in the previous message here:

https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm

The sales of some companies without XR version approved can be made by some kind of sales collaboration, but definitely Fred gove us XR version sales.

Only big question is, why MNK can make only 1-2% the sales Accord and Lupin does. This is the main question now. Can MNK and IPCI do something about it.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist